Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02602730 · ClinicalTrials.gov registry record · Phase 2

Internet-Based Nonsmoking Program for Postpartum Women

A Phase 2 study, sponsored by Oregon Center for Applied Science.

Completed
Registry status
Phase 2
Development phase
307
Enrollment target

NCT02602730: Completed Phase 2 study, sponsored by Oregon Center for Applied Science.

NCT02602730 is a Phase 2 study that has completed, run by Oregon Center for Applied Science. The registered enrollment target is 307 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (131% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02602730, a Phase 2 study, has completed, sponsored by Oregon Center for Applied Science.

COMPLETED
Registry status
Phase 2
Development phase
307 participants
Enrollment target

Study Summary

This project developed and evaluated an Internet-based interactive program with digital coaching designed to assist two groups of smokers in quitting smoking: (1) pregnant smokers and (2) general-population smokers (i.e., men and non-pregnant women). Program content was based on the U.S. Department of Health and Human Services Clinical Practice Guidelines, "Treating Tobacco Use and Dependence: 2008 Update" (Fiore et al., 2008) and input from project consultants.

Primary Outcome

Smoking cessation as measured by number of cigarettes smoked in the last 7 days. We will use an intent-to-treat statistical analysis, a conservative approach that classifies all non-responders as smokers.

Interventions

  • BEHAVIORAL Break the Chain
  • BEHAVIORAL Clearing the Air

Trial Details

FieldValue
Enrollment Target 307 participants
Start Date 2012-02
Est. Completion 2013-08
Phase Phase 2
Oregon Center for Applied Science

14 total trials

What the finished NCT02602730 record still lists

NCT02602730 is an interventional study that assigns participants to a tested intervention. The registered 307 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (131% higher).

The record links to 0 conditions, and to 2 interventions - of which Break the Chain is the first listed.

NCT02602730 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02602730 about?

NCT02602730 is a clinical study titled "Internet-Based Nonsmoking Program for Postpartum Women". This project developed and evaluated an Internet-based interactive program with digital coaching designed to assist two groups of smokers in quitting smoking: (1) pregnant smokers and (2) general-population smokers (i.e., men and non-pregnant women). Program content was based on the U.S. Department ...

What is the current status of trial NCT02602730?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 307 participants. The study started on 2012-02. Estimated completion is 2013-08.

What interventions are being tested in trial NCT02602730?

The interventions under investigation include: Break the Chain (BEHAVIORAL), Clearing the Air (BEHAVIORAL).

Who is sponsoring clinical trial NCT02602730?

This trial is sponsored by Oregon Center for Applied Science, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02602730's enrollment target sits among peer trials

307 165th of 2000 higher than 1,836 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05433142 · 307 participants · Phase 1

    Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • NCT04162938 · 308 participants · NA

    Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum

  • NCT04955795 · 308 participants · NA

    Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA

  • NCT06090539 · 308 participants · Phase 1

    A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02602730, the US trial registry maintained by the National Library of Medicine. NCT02602730 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.